Latest market price
9.10
-0.41-4.31%
OverviewShort InterestFilings
TLXQT37Telix Pharmaceuticals Limited·NASDAQ
9.10-4.31%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 29, 20266-KForeign issuer report
Oct 21, 20266-KForeign issuer report
Sep 30, 20266-KForeign issuer report
Sep 21, 20266-KForeign issuer report
Sep 14, 20266-KForeign issuer report
Sep 14, 20264Statement of changes in beneficial ownership
Sep 02, 20266-KForeign issuer report
Sep 01, 20266-KForeign issuer report
Aug 20, 20266-KForeign issuer report
Jul 21, 20266-KForeign issuer report
Jul 02, 20266-KForeign issuer report
May 21, 20266-KForeign issuer report
May 18, 20263Initial statement of beneficial ownership
May 18, 20263Initial statement of beneficial ownership
May 18, 20263Initial statement of beneficial ownership
May 06, 20264Statement of changes in beneficial ownership
Apr 23, 20266-KForeign issuer report
Apr 21, 20266-KForeign issuer report
Apr 20, 20266-KForeign issuer report
Apr 14, 20266-KForeign issuer report
Apr 14, 20266-KForeign issuer report
Apr 13, 20266-KForeign issuer report
Apr 10, 20266-KForeign issuer report
Apr 09, 20266-KForeign issuer report
Apr 07, 20266-KForeign issuer report
#1 / 25 of 106
Page
▼
/ 5